Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACB
2351
Aurora Cannabis
ACB
$185M
| $640K | ﹤0.01% |
9,244
| – | – |
|
2352
Malibu Boats
MBUU
$567M
| $640K | ﹤0.01% |
9,135
+4,067
| +80% | +$305K |
|
2353
Arcus Biosciences
RCUS
$3.64B
| $640K | ﹤0.01% |
18,364
+8,095
| +79% | +$252K |
|
2354
Cognyte Software
CGNT
$680M
| $639K | ﹤0.01% |
31,088
-2,684
| -8% | -$68.6K |
|
|
GSKY
2355
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $633K | ﹤0.01% |
56,622
+24,318
| +75% | +$191K |
|
2356
Quanterix
QTRX
$190M
| $632K | ﹤0.01% |
12,673
+5,569
| +78% | +$287K |
|
2357
Seneca Foods Class A
SENEA
$1.21B
| $630K | ﹤0.01% |
13,056
-336
| -3% | -$17K |
|
|
TUYA
2358
Tuya Inc
TUYA
$1.1B
| $630K | ﹤0.01% |
+69,416
| New | +$1.07M |
|
|
EVOP
2359
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $628K | ﹤0.01% |
26,553
+14,013
| +112% | +$372K |
|
2360
Seer Inc
SEER
$120M
| $626K | ﹤0.01% |
18,118
+12,887
| +246% | +$443K |
|
|
HT
2361
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $626K | ﹤0.01% |
67,098
-6,720
| -9% | -$63.8K |
|
2362
Columbia Financial
CLBK
$1.13B
| $624K | ﹤0.01% |
33,704
+9,324
| +38% | +$167K |
|
2363
Liberty Media Series A
FWONA
$23.6B
| $621K | ﹤0.01% |
13,773
-2,612
| -16% | -$110K |
|
|
PAYA
2364
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $618K | ﹤0.01% |
56,856
+27,956
| +97% | +$301K |
|
2365
First Interstate BancSystem
FIBK
$3.58B
| $616K | ﹤0.01% |
15,315
+8,131
| +113% | +$345K |
|
|
MYOV
2366
DELISTED
Myovant Sciences Ltd.
MYOV
| $616K | ﹤0.01% |
27,469
+7,178
| +35% | +$158K |
|
2367
Stride
LRN
$3.43B
| $615K | ﹤0.01% |
17,122
+8,213
| +92% | +$269K |
|
2368
UNIFI
UFI
$134M
| $615K | ﹤0.01% |
28,025
-1,859
| -6% | -$42.3K |
|
2369
Conduent
CNDT
$264M
| $613K | ﹤0.01% |
93,018
-141,993
| -60% | -$975K |
|
|
BWIN
2370
Baldwin Insurance Group
BWIN
$2.86B
| $609K | ﹤0.01% |
18,282
+10,827
| +145% | +$339K |
|
2371
Acco Brands
ACCO
$407M
| $607K | ﹤0.01% |
70,687
+18,676
| +36% | +$165K |
|
|
CMPS
2372
Compass Pathways
CMPS
$1.83B
| $605K | ﹤0.01% |
20,287
+6,241
| +44% | +$209K |
|
|
HMHC
2373
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $605K | ﹤0.01% |
45,054
+24,930
| +124% | +$314K |
|
2374
Porch Group
PRCH
$1.8B
| $600K | ﹤0.01% |
33,928
+28,155
| +488% | +$528K |
|
2375
Castle Biosciences
CSTL
$979M
| $596K | ﹤0.01% |
8,956
+3,894
| +77% | +$274K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.